Melatonin Suppresses the Growth of Ovarian Cancer Cell Lines (OVCAR-429 and PA-1) and Potentiates the Effect of G1 Arrest by Targeting CDKs

Print
Published on Monday, 08 February 2016

Abstract

Melatonin is found in animals as well as plants. In animals, it is a hormone that anticipates the daily onset of darkness and regulates physiological functions, such as sleep timing, blood pressure, and reproduction.

Melatonin has also been found to have anti-tumor properties.

Malignant cancers are the most common cause of death, and the mortality rate of ovarian tumor is the highest among gynecological diseases.

This study investigated the anti-tumor effects of melatonin on the ovarian cancer lines, OVCAR-429 and PA-1.

We observed the accumulation of melatonin-treated cells in the G₁ phase due to the down-regulation of CDK 2 and 4.

Our results suggest that in addition to the known effects on prevention, melatonin may also provide anti-tumor activity in established ovarian cancer.

 

 

About this publication.

 

See also About Melatonin.